The Chemours Company (CC) financial statements and ratios from SEC XBRL: revenue $5.81B (TTM), net margin -6.6%, revenue growth 1.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $5.81B |
| Net Margin | -6.6% |
| Revenue Growth (YoY) | 1.0% |
| EPS Growth (YoY) | 533.3% |
| FCF Growth (YoY) | -52.6% |
| EV / EBITDA | 185.1 |
| Price / Book | 11.11 |
| Price / Sales | 0.41 |
| FCF Yield | 6.4% |
| DCF Value (model) | $4.46 |
| DCF Upside vs Price | -72.1% |
| Altman Z-Score | 1.31 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Materials) | 25.9 |
CC overview · CC earnings · CC KPIs · CC investor relations · CC ownership · CC peers · CC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.